(Q36499227)

14 August 2017

Oncolytic adenoviruses as antiglioma agents (English)

1 reference

14 August 2017

1 reference

1 reference

Candelaria Gomez-Manzano

series ordinal

4

object named as

Candelaria Gomez-Manzano

1 reference

14 August 2017

5

Juan Fueyo

1 reference

14 August 2017

Hong Jiang

1

1 reference

PubMed ID

16759161

14 August 2017

Frank McCormick

series ordinal

2

1 reference

PubMed ID

16759161

14 August 2017

Frederick F Lang

series ordinal

3

1 reference

14 August 2017

1 May 2006

1 reference

Expert Review of Anticancer Therapy

14 August 2017

1 reference

14 August 2017

6

1 reference

14 August 2017

697-708

1 reference

14 August 2017

5

1 reference

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

14 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.697

Replication-selective viruses for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.697

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.697

ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.697

Late viral RNA export, rather than p53 inactivation, determines ONYX-015 tumor selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.697

a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.697

A phase I open-label, dose-escalation, multi-institutional trial of injection with an E1B-Attenuated adenovirus, ONYX-015, into the peritumoral region of recurrent malignant gliomas, in the adjuvant setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.697

Heat shock phenocopies E1B-55K late functions and selectively sensitizes refractory tumor cells to ONYX-015 oncolytic viral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.697

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.697

Cellular targets for transformation by the adenovirus E1A proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.697

Evaluation of E1-mutant adenoviruses as conditionally replicating agents for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.697

A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.697

Preclinical Characterization of the Antiglioma Activity of a Tropism-Enhanced Adenovirus Targeted to the Retinoblastoma Pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.697

Downmodulation of E1A protein expression as a novel strategy to design cancer-selective adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.697

A novel E1A-E1B mutant adenovirus induces glioma regression in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.697

Re-engineering adenovirus regulatory pathways to enhance oncolytic specificity and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.697

A novel tumor-specific replication-restricted adenoviral vector for gene therapy of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.697

Tumor-selective transgene expression in vivo mediated by an E2F-responsive adenoviral vector.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.697

New oncolytic adenoviruses with hypoxia- and estrogen receptor-regulated replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.697

Selectively replicating adenoviruses targeting deregulated E2F activity are potent, systemic antitumor agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.697

Telomeres and cancer: a tale with many endings

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.697

Telomerase-dependent oncolytic adenovirus for cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.697

Telomerase-specific replication-selective virotherapy for human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.697

Ad-mTERT-delta19, a conditional replication-competent adenovirus driven by the human telomerase promoter, selectively replicates in and elicits cytopathic effect in a cancer cell-specific manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.697

Telomerase as a therapeutic target for malignant gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.697

HIF-1 as a target for drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.697

Hypoxia inducible factor as a cancer drug target

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.697

A novel hypoxia-inducible factor (HIF) activated oncolytic adenovirus for cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.697

Killing of brain tumor cells by hypoxia-responsive element mediated expression of BAX

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.697

Adenoviruses with Tcf binding sites in multiple early promoters show enhanced selectivity for tumour cells with constitutive activation of the wnt signalling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.697

Cyr61 is overexpressed in gliomas and involved in integrin-linked kinase-mediated Akt and beta-catenin-TCF/Lef signaling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.697

Infectivity enhanced, cyclooxygenase-2 promoter-based conditionally replicative adenovirus for pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.697

Infectivity-enhanced cyclooxygenase-2-based conditionally replicative adenoviruses for esophageal adenocarcinoma treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.697

The eicosanoid cascade: possible role in gliomas and meningiomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.697

A mouse model for glioma: biology, pathology, and therapeutic opportunities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.697

Glioma/glioblastoma-specific adenoviral gene expression using the nestin gene regulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.697

Inhibition of glioma cells in vitro and in vivo using a recombinant adenoviral vector containing an astrocyte-specific promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.697

Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.697

HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.697

Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.697

Reducing the native tropism of adenovirus vectors requires removal of both CAR and integrin interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.697

Adenovirus binding to the coxsackievirus and adenovirus receptor or integrins is not required to elicit brain inflammation but is necessary to transduce specific neural cell types

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.697

Heparan sulfate glycosaminoglycans are receptors sufficient to mediate the initial binding of adenovirus types 2 and 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.697

Receptor interactions involved in adenoviral-mediated gene delivery after systemic administration in non-human primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.697

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.697

Insertion of an RGD motif into the HI loop of adenovirus fiber protein alters the distribution of transgene expression of the systemically administered vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.697

Engineering of adenovirus vectors containing heterologous peptide sequences in the C terminus of capsid protein IX.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.697

Genetic targeting of an adenovirus vector via replacement of the fiber protein with the phage T4 fibritin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.697

Genetically targeted adenovirus vector directed to CD40-expressing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.697

Efficient adenoviral gene transfer to kidney cortical vasculature utilizing a fiber modified vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.697

The coxsackievirus and adenovirus receptor acts as a tumour suppressor in malignant glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.697

Dependence of efficient adenoviral gene delivery in malignant glioma cells on the expression levels of the Coxsackievirus and adenovirus receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.697

Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.697

Glioma-associated antigen expression in oligodendroglial neoplasms. Tenascin and epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.697

EGF mutant receptor vIII as a molecular target in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.697

Conditionally replicative adenovirus expressing a targeting adapter molecule exhibits enhanced oncolytic potency on CAR-deficient tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.697

Fibroblast growth factors, their receptors and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.697

The role of plasminogen activators in the regulation of connective tissue metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.697

Targeting the urokinase plasminogen activator receptor enhances gene transfer to human airway epithelia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.697

Future prospects for oncolytic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.697

Double suicide gene therapy augments the antitumor activity of a replication-competent lytic adenovirus through enhanced cytotoxicity and radiosensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.697

Efficacy and toxicity of replication-competent adenovirus-mediated double suicide gene therapy in combination with radiation therapy in an orthotopic mouse prostate cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.697

Radiation increases the activity of oncolytic adenovirus cancer gene therapy vectors that overexpress the ADP (E3-11.6K) protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.697

Potentiation of radiation therapy by the oncolytic adenovirus dl1520 (ONYX-015) in human malignant glioma xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.697

21 January 2018

Identifiers

DOI

10.1586/14737140.6.5.697

1 reference

14 August 2017

1 reference

PubMed ID

16759161